FY2025 · period end Dec '25 · from the 10-K filed Feb 10, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $5.14B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000879169-26-000048 | Jul 6, 2026 | Jul 6, 2026 | Jul 6, 2026 20:06 UTC | EDGAR |
| 8-K | 0000879169-26-000046 | Jun 22, 2026 | Jun 22, 2026 | Jun 22, 2026 11:00 UTC | EDGAR |
| 8-K | 0000879169-26-000043 | Jun 8, 2026 | Jun 9, 2026 | Jun 9, 2026 20:06 UTC | EDGAR |
| 8-K | 0000879169-26-000040 | Jun 8, 2026 | Jun 8, 2026 | Jun 8, 2026 11:05 UTC | EDGAR |
| 8-K | 0000879169-26-000023 | Apr 28, 2026 | Apr 28, 2026 | Apr 28, 2026 11:03 UTC | EDGAR |
| 10-Q | 0000879169-26-000026 | Mar 31, 2026 | Apr 28, 2026 | Apr 28, 2026 20:02 UTC | EDGAR |
| 8-K | 0000879169-26-000018 | Mar 26, 2026 | Mar 30, 2026 | Mar 30, 2026 21:35 UTC | EDGAR |
| 8-K | 0000879169-26-000016 | Mar 25, 2026 | Mar 26, 2026 | Mar 26, 2026 12:38 UTC | EDGAR |
Direct links to SEC EDGAR. INCY has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Assets·As of Dec 31, 2014
Notable restatementwas$830.1M
Revised down in a 10-K.
Liabilities·As of Dec 31, 2014
Notable restatementwas$911.7M
Revised down in a 10-K.
Operating Income (Loss)·Q2 2017
Minor restatementwas$7.2M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Financing Activities·FY 2016
Major restatementwas$58.6M
Revised down in a 10-K.
Assets, Current·As of Dec 31, 2014
Notable restatementwas$699.2M
Revised down in a 10-K.
Other Nonoperating Income (Expense)·FY 2023
Major restatementwas$172.3M
Revised down in a 10-K.
INCY is not the only one.
See every restatement we've found across the market — or get an alert the next time INCY revises a number.
Restatements are detected by comparing every vintage of a fact across all of INCYTE CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows INCY's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling INCYTE CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on INCY yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on INCY and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $3.70B |
| $3.39B |
| $2.99B |
| Gross Profit | $4.77B | $3.93B | $3.44B | $3.19B | $2.84B |
|---|
| Operating Income | $1.51B | $0.06B | $0.62B | $0.58B | $0.59B |
|---|
| Net Income | $1.29B | $0.03B | $0.60B | $0.34B | $0.95B |
|---|
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B |
| Cash & Equivalents | $3.10B | $1.69B | $3.22B | $2.95B | $2.06B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.41B | $0.34B | $0.50B | $0.97B | $0.75B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 92.8% | 92.6% | 93.1% | 93.9% | 94.9% |
| Operating Margin | 0.3% | 0.0% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.3% | 0.0% | 0.2% | 0.1% | 0.3% |
| Return on Equity | 29.9% | 0.8% | 12.5% | 8.4% | 29.7% |
| Return on Assets | 20.7% | 0.5% | 9.5% | 6.3% | 22.3% |
| Debt / Equity | — | — | — | — | — |
